A multidisciplinary team (MDT) approach is necessary in treating metastatic breast cancer in order to provide optimal care. This article, published in JNCCN, reviews the findings of an educational needs assessment of the multidisciplinary breast cancer management team.
Ongoing studies are expected to provide information about how to sequence cabozantinib in clinical practice.
Researchers found that, among men previously treated for lymphoma, the incidence of breast cancer is higher than in the general population.
Cancer Therapy Advisor interviewed Keith Flaherty, MD, about recent findings regarding targeted therapies for melanoma.
More studies are needed to define the role of intratumoral androgen production and mCRPC resistance to hormonal therapies, and to determine if inhibitors of other steroidogenesis enzymes can be synergistic with abiraterone.
Clinicians are advocating that sexual dysfunction after cancer, which affects a large proportion of survivors, be addressed as a serious quality of life issue.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- PD-L1 Expression Predicts Response to PD-1/PD-L1 Inhibition
- Breast Cancer Risk Higher in Men Previously Treated for Lymphoma According to Research
- Clinicians Advocate for Patients With Sexual Dysfunction After Cancer, A Quality of Life Issue
- Prostate Cancer Treatment: Abiraterone and Other Hormonal Therapies Being Studied
- Young Patients With CLL At Risk for Secondary Cancers